COMPARISON OF HYPOMETHYLATING AGENTS FOR THE TREATMENT OF MYELODYSPLASTIC SYNDROME: RETROSPECTIVE ANALYSIS, SINGLE CENTER EXPERIENCE

被引：0
|
作者：
Unal, A. [1 ]
Keni, N. [1 ]
Yildizhan, E. [1 ]
Turak, E. [1 ]
Kaynar, L. [1 ]
Zararsiz, G. [1 ]
Uysal, E. [1 ]
Eser, B. [1 ]
Cetin, M. [1 ]
机构：
[1] Erciyes Univ, Dept Hematol, Kayseri, Turkey
来源：
LEUKEMIA RESEARCH | 2017年 / 61卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
OP-22
引用
收藏
页码：S22 / S22
页数：1
相关论文
共 50 条
  • [1] THE EXPERIENCE OF A SINGLE CENTER OF HEMATOLOGY IN THE TREATMENT WITH HYPOMETHYLATING AGENTS
    Georgescu, D.
    Popescu, M.
    Tevet, M.
    Patrinoiu, O.
    Murat, M.
    Ciuhu, A.
    LEUKEMIA RESEARCH, 2015, 39 : S95 - S96
  • [2] Results of Treatment With Hypomethylating Agents Versus Hypomethylating Agents/Venetoclax in Patients With AML Single-Center Experience
    Patino, Ana Flavia
    Brulc, Erika
    Conca, Alberto Gimenez
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S289 - S289
  • [3] Hypomethylating agents for the treatment of myelodysplastic syndromes
    Itzykson, Raphael
    Fenaux, Pierre
    BULLETIN DU CANCER, 2011, 98 (08) : 927 - 934
  • [4] Predictive Factors of Treatment Response to Hypomethylating Agents in Patients with Myelodysplastic Syndrome
    Wu, Ping
    Du, Xin
    Weng, Jianyu
    Deng, Chengxin
    Geng, Suxia
    Lu, Zesheng
    Lai, Peilong
    Huang, Xin
    Luo, Chengwei
    BLOOD, 2015, 126 (23)
  • [5] Novel therapeutic strategies using hypomethylating agents in the treatment of myelodysplastic syndrome
    Takayuki Ishikawa
    International Journal of Clinical Oncology, 2014, 19 : 10 - 15
  • [6] Making the most of hypomethylating agents in myelodysplastic syndrome
    Bhatt, Geetika
    Blum, William
    CURRENT OPINION IN HEMATOLOGY, 2017, 24 (02) : 79 - 88
  • [7] Novel therapeutic strategies using hypomethylating agents in the treatment of myelodysplastic syndrome
    Ishikawa, Takayuki
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2014, 19 (01) : 10 - 15
  • [8] Activity of Hypomethylating Agents in the Treatment of Therapy-Related Myelodysplastic Syndrome
    Pierola, Ana Alfonso
    Montalban-Bravo, Guillermo
    Takahashi, Koichi
    Feng Wang
    Song Xingzhi
    Jabbour, Elias J.
    Kadia, Tapan M.
    Ravandi, Farhad
    Cortes, Jorge E.
    DiNardo, Courtney D.
    Daver, Naval G.
    Borthakur, Gautam
    Pemmaraju, Naveen
    Konopleva, Marina
    Bueso-Ramos, Carlos E.
    Patel, Keyur
    Futreal, Andrew
    Pierce, Sherry
    Kantarjian, Hagop M.
    Garcia-Manero, Guillermo
    BLOOD, 2016, 128 (22)
  • [9] RETROSPECTIVE EVALUATION OF AZACITIDINE MONOTHERAPY IN PATIENTS WITH MYELODYSPLASTIC SYNDROME: A SINGLE CENTER EXPERIENCE
    Kaya, A.
    Tekgunduz, E.
    Iskender, D.
    Batgi, H.
    Bekdemir, F.
    Altuntas, F.
    LEUKEMIA RESEARCH, 2015, 39 : S133 - S134
  • [10] Transplantation for myelodysplastic syndrome in the era of hypomethylating agents
    Gerds, Aaron T.
    Deeg, H. Joachim
    CURRENT OPINION IN HEMATOLOGY, 2012, 19 (02) : 71 - 75
12345